Sign in

You're signed outSign in or to get full access.

Martin Cohen

Chairman of the Board at COHEN & STEERSCOHEN & STEERS
Board

About Martin Cohen

Martin Cohen (age 76) is Chairman of the Board and a director of Cohen & Steers, Inc.; he has served as a director since August 2004 and was co-CEO/co-chairman until 2014, then Executive Chairman until retiring from the company in February 2016. He co-founded Cohen & Steers in 1986 and previously led pioneering real estate securities funds at National Securities and Research Corporation (1985) and Citibank (1980). Cohen holds a BS from City College of New York and an MBA from New York University .

Past Roles

OrganizationRoleTenureCommittees/Impact
Cohen & Steers, Inc.Co-CEO & Co-Chairman1986–2014Co-founded firm; led strategy and growth; established category leadership in real assets
Cohen & Steers, Inc.Executive Chairman2014–Feb 2016Oversight of Board and transition to non-executive chair
Cohen & Steers, Inc.Chairman of the BoardAug 2004–presentChairs Board; chairs non-management executive sessions
National Securities & Research Corp.Senior VP & Portfolio Manager1984–1986Organized and managed the nation’s first real estate securities mutual fund (1985)
CitibankVice President1976–1981Organized and managed the Citibank Real Estate Stock Fund (1980)

External Roles

OrganizationRoleTenureNotes
National Association of Real Estate Investment Trusts (NAREIT)Board of Governors (former)Not disclosedFormer governance role in industry association

Board Governance

  • Independence status: The Board determined Martin Cohen is not independent under NYSE standards; Messrs. Cohen, Steers, and Harvey were classified as non-independent directors as of Feb 20, 2025 .
  • Committee assignments: Cohen is not listed as a member of the Audit, Compensation, or Nominating Committees; these committees are composed entirely of independent directors .
  • Chair roles: He serves as non-executive Chairman of the Board and chairs executive sessions of non-management directors; executive sessions of only independent directors are chaired on a rotational basis by an independent director .
  • Board leadership structure: CNS separates the Chairman and CEO roles (since 2014) and does not have a lead independent director; the Board and Nominating Committee believe a lead independent is unnecessary given the majority-independent composition and governance processes .
  • Attendance and engagement:
    • Meetings held in 2024: Board (6), Audit (8), Compensation (3), Nominating (3) .
    • Attendance: Each director attended at least 75% of meetings of the Board and committees on which they served; all directors serving at the time attended the 2024 annual meeting .
BodyMeetings in 2024Attendance disclosure
Board of Directors6 Each director ≥75%
Audit Committee8 Each director ≥75%
Compensation Committee3 Each director ≥75%
Nominating Committee3 Each director ≥75%

Fixed Compensation

  • Structure for non-management directors: Annual retainer $210,000 ($100,000 cash; $110,000 RSUs, granted quarterly, 100% vested at grant, delivered in three years; dividends paid in cash); additional retainers: Chairman of the Board $180,000 cash; Audit Chair $15,000; Compensation Chair $7,500; Nominating Chair $5,000; Audit Committee members $15,000; Compensation Committee members $7,500; Nominating Committee members $5,000 (quarterly in arrears) .
  • Co-investment opportunity: Directors/officers may co-invest in certain company-advised vehicles without management fees or carried interest .
2024 Director Compensation (Cohen)Amount ($)
Fees Earned or Paid in Cash280,167
Stock Awards (RSUs, grant-date fair value)109,860
All Other Compensation (medical/dental employer portion per employment agreement)23,701
Total413,728

Performance Compensation

  • Non-management director compensation is not performance-based; RSUs are fully vested at grant and delivered after three years; dividends on common stock are paid in cash to non-management directors .
  • Quarterly RSU grant detail for 2024 (Cohen):
Grant DateRSUs GrantedGrant-Date Fair Value ($)VestingDelivery
Jan 2, 2024365 27,467 100% vested at grant Delivered on third anniversary
Apr 1, 2024362 27,454 100% vested at grant Delivered on third anniversary
Jul 1, 2024383 27,482 100% vested at grant Delivered on third anniversary
Oct 1, 2024291 27,457 100% vested at grant Delivered on third anniversary

Other Directorships & Interlocks

  • Current public company boards: None disclosed for Martin Cohen beyond CNS .
  • Interlocks/related roles: Not disclosed; Board independence determination noted some directors are or are considering becoming investors in company-managed funds; Board did not deem this material .

Expertise & Qualifications

  • Real assets and listed real estate pioneer; co-founded specialized asset manager in 1986 .
  • Track record launching first real estate securities mutual fund (1985) and Citibank Real Estate Stock Fund (1980) .
  • Education: BS (City College of New York), MBA (NYU) .
  • Industry governance: Former NAREIT Board of Governors .

Equity Ownership

  • Cohen is a significant shareholder and 10% beneficial owner; his ownership provides strong alignment but also concentrated influence over outcomes requiring shareholder approval .
HolderShares Beneficially Owned% of OutstandingRSUs HeldNotable Ownership Details
Martin Cohen9,015,216 17.8% 4,326 Includes 8,171,461 shares in the Martin Cohen 2018 Revocable Trust; 315 shares to be delivered on Apr 1, 2025 upon RSU settlement
  • Company policy: Directors and employees are prohibited from hedging company securities; the proxy notes individuals may hold shares in accounts with a margin feature, but no pledging is disclosed; the company does not maintain formal director/executive stock ownership guidelines, citing meaningful collective ownership .

Insider Trades (recent)

DateFilingLinkNotes
Apr 2, 2025Form 4https://www.sec.gov/Archives/edgar/data/1284812/000128481225000146/0001284812-25-000146-index.htmReporting person: COHEN MARTIN (changes in beneficial ownership)
Nov 13, 2024Form 4https://www.sec.gov/Archives/edgar/data/1284812/000128481224000366/0001284812-24-000366-index.htmChanges in beneficial ownership (trust-related holdings referenced by third-party summaries)
Aug 28, 2024Form 4http://pdf.secdatabase.com/1438/0001284812-24-000320.pdfReporting date Aug 27, 2024 (Revocable Trust referenced in summaries)
Jul 2, 2024Form 4http://pdf.secdatabase.com/1375/0001284812-24-000257.pdfReporting date Jul 1, 2024; shares held by the Martin Cohen 2018 Revocable Trust (per explanation)

Governance Assessment

  • Strengths

    • Founder with deep domain expertise and long-tenured leadership in real assets; valuable strategic and historical knowledge for Board oversight .
    • Clear separation of Chair and CEO roles; structured committee system with fully independent membership; regular executive sessions of independent directors .
    • Robust insider trading and hedging prohibitions; formal clawback policy adopted for incentive compensation (executives) per SEC/NYSE rules .
  • Concerns and potential red flags

    • Concentrated ownership and control: Cohen beneficially owns 17.8% of outstanding shares; combined founder holdings (Cohen and Steers) confer meaningful influence over director elections and shareholder approvals, potentially reducing minority shareholder power .
    • Independence optics: Chairman is not independent; Board lacks a lead independent director; Cohen chairs non-management executive sessions, which may limit purely independent oversight dynamics .
    • Related-party/perquisite exposure: Continued employer-paid portion of medical/dental coverage under a prior employment agreement is unusual for non-management directors; modest in size but notable for governance optics .
    • Co-investment arrangements: Directors/officers may co-invest in company-managed vehicles without fees/carry; while customary in asset management, it warrants monitoring for potential conflicts in fund oversight decisions .
    • Ownership guidelines: Absence of formal stock ownership guidelines for directors/executives (despite high insider ownership) may reduce codified alignment standards, though practical alignment is strong .
  • Attendance/Engagement: 2024 attendance exceeded 75% for all directors; Cohen’s role includes chairing executive sessions and Board leadership, indicating active engagement .

Other Notes and Policies

  • Related party transactions policy requires Audit Committee or disinterested independent approval for Item 404(a) transactions over $120,000; routine client/product transactions at market terms are exempt .
  • Board diversity disclosure and ongoing governance guideline review suggest attention to board composition and oversight processes .

Overall, Cohen’s founder experience and significant ownership provide alignment and continuity but present independence and concentration risks. The lack of a lead independent director and ongoing perquisite coverage are governance signals to monitor, alongside any future related-party transactions or changes in committee structures .